These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11192368)

  • 1. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
    Mocanu MM; Baxter GF; Yue Y; Critz SD; Yellon DM
    Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts.
    Nakano A; Cohen MV; Critz S; Downey JM
    Basic Res Cardiol; 2000 Dec; 95(6):466-71. PubMed ID: 11192367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
    Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
    J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
    Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
    J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK.
    Lochner A; Genade S; Hattingh S; Marais E; Huisamen B; Moolman JA
    Cardiovasc Drugs Ther; 2003 May; 17(3):217-30. PubMed ID: 14574080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart.
    Bell JR; Eaton P; Shattock MJ
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):126-34. PubMed ID: 17892505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
    Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
    Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 MAPK activity is not increased early during sustained coronary artery occlusion in preconditioned versus control rabbit heart.
    Gysembergh A; Simkhovich BZ; Kloner RA; Przyklenk K
    J Mol Cell Cardiol; 2001 Apr; 33(4):681-90. PubMed ID: 11273721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning.
    Marais E; Genade S; Salie R; Huisamen B; Maritz S; Moolman JA; Lochner A
    Basic Res Cardiol; 2005 Jan; 100(1):35-47. PubMed ID: 15526116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart.
    Sanada S; Kitakaze M; Papst PJ; Hatanaka K; Asanuma H; Aki T; Shinozaki Y; Ogita H; Node K; Takashima S; Asakura M; Yamada J; Fukushima T; Ogai A; Kuzuya T; Mori H; Terada N; Yoshida K; Hori M
    Circ Res; 2001 Feb; 88(2):175-80. PubMed ID: 11157669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
    Weinbrenner C; Liu GS; Cohen MV; Downey JM
    J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CREB activation and ischaemic preconditioning.
    Marais E; Genade S; Lochner A
    Cardiovasc Drugs Ther; 2008 Feb; 22(1):3-17. PubMed ID: 18205034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning.
    Schneider S; Chen W; Hou J; Steenbergen C; Murphy E
    Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H499-508. PubMed ID: 11158945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
    Fan WJ; van Vuuren D; Genade S; Lochner A
    Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning.
    Zhang Y; Gu EW; Zhang J; Chen ZW
    Chin Med J (Engl); 2007 May; 120(9):777-81. PubMed ID: 17531118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAPKs regulation of ischemic preconditioning.
    Sato M; Cordis GA; Maulik N; Das DK
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H901-7. PubMed ID: 10993748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes.
    Saurin AT; Martin JL; Heads RJ; Foley C; Mockridge JW; Wright MJ; Wang Y; Marber MS
    FASEB J; 2000 Nov; 14(14):2237-46. PubMed ID: 11053245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
    Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
    Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.